glycopyrrolate
Generic: glycopyrrolate
Labeler: hf acquisition co llc, dba healthfirstDrug Facts
Product Profile
Brand Name
glycopyrrolate
Generic Name
glycopyrrolate
Labeler
hf acquisition co llc, dba healthfirst
Dosage Form
INJECTION
Routes
Active Ingredients
glycopyrrolate .2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51662-1487
Product ID
51662-1487_1200a572-e002-a795-e063-6294a90a59a0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090963
Listing Expiration
2026-12-31
Marketing Start
2020-01-11
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516621487
Hyphenated Format
51662-1487
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
glycopyrrolate (source: ndc)
Generic Name
glycopyrrolate (source: ndc)
Application Number
ANDA090963 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .2 mg/mL
Packaging
- 1 mL in 1 VIAL (51662-1487-1)
- 25 POUCH in 1 BOX (51662-1487-3) / 1 VIAL in 1 POUCH (51662-1487-2) / 1 mL in 1 VIAL
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "1200a572-e002-a795-e063-6294a90a59a0", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["1731582"], "spl_set_id": ["9be0ad4e-3efa-1a24-e053-2995a90a60d5"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL (51662-1487-1)", "package_ndc": "51662-1487-1", "marketing_start_date": "20200111"}, {"sample": false, "description": "25 POUCH in 1 BOX (51662-1487-3) / 1 VIAL in 1 POUCH (51662-1487-2) / 1 mL in 1 VIAL", "package_ndc": "51662-1487-3", "marketing_start_date": "20210511"}], "brand_name": "GLYCOPYRROLATE", "product_id": "51662-1487_1200a572-e002-a795-e063-6294a90a59a0", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "51662-1487", "generic_name": "GLYCOPYRROLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA090963", "marketing_category": "ANDA", "marketing_start_date": "20200111", "listing_expiration_date": "20261231"}